Publications by authors named "Yusuke Kamiga"
Med Princ Pract
December 2024
Article Synopsis
- Imeglimin, a new antidiabetic medication, was tested as an add-on therapy to metformin in patients with type 2 diabetes to see how it affects glucose levels and variability over 24 hours.
- The study involved 30 patients using continuous glucose monitoring (CGM) for 14 days, with imeglimin introduced on day 7, measuring effects before and after treatment.
- Results showed a significant decrease in 24-hour average glucose levels and increased time spent within the target glucose range, indicating improved glycemic control and variability with imeglimin addition, especially in those with higher baseline HDL cholesterol levels.
